Timothy C. Dec - 23 Aug 2021 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SUPN	Employee Stock Option (Right to Buy)	Award	$0	+85,000		$0.000000	85,000	23 Aug 2021	Common Stock	85,000	$25.09	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option vests in four equal annual installments beginning on August 23, 2021.